Verma Sandeep, Singh Ruchi, Sharma Vanila, Bumb Ram Avtar, Negi Narendra Singh, Ramesh V, Salotra Poonam
National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, 110029, India.
Department of Skin, STD and Leprosy, S. P. Medical College, Bikaner, India.
BMC Infect Dis. 2017 Mar 23;17(1):223. doi: 10.1186/s12879-017-2318-8.
Leishmaniasis is a spectrum of diseases with great relevance to public health. Conventional diagnostic methods are time consuming, needing trained personnel. A robust, rapid and cost effective diagnostic test is warranted for on-time diagnosis and field application.
We have developed a loop mediated isothermal amplification (LAMP) assay with primers (n = 6) based on Leishmania donovani kDNA for detection of Leishmania infection, using a closed tube to prevent cross-contamination. The assay was used to detect Leishmania infection in biological samples obtained from patients of visceral leishmaniasis (VL), post kala-azar dermal leishmaniasis (PKDL) and cutaneous leishmaniasis (CL).
The assay was positive for L. donovani, L. tropica and L. major parasites, with the highest sensitivity towards L. donovani (1 fg DNA). The high sensitivity of the assay for detection of L. donovani was reflected in its ability to detect parasite DNA within 30 min of amplification time with a threshold detection limit of ≥25 copies per reaction. The assay detected parasite in 64 of 66 VL blood samples (sensitivity, 96.9%; 95% CI: 89.6-99.2%), 15 of 15 VL bone marrow aspirate samples (sensitivity, 100%; 95% CI:79.6-100%), 65 of 67 PKDL tissue biopsy samples (sensitivity, 97%; 95% CI:89.7-99.2%). The assay was evaluated in a few cases of CL wherein it was found positive in 8 of 10 tissue biopsies (sensitivity, 80%; 95% CI: 49-94.3%). The assay was negative in all control blood (n = 76) and tissue biopsy (n = 24) samples (specificity, 100%; 95% CI: 96.3-100%). Further, the assay was evaluated for its utility in assessment of cure in treated VL and PKDL patients. The assay detected parasite DNA in 2 of 20VL blood samples and 2 of 21 PKDL tissue samples. Out of 4 cases that were positive for parasite DNA at post treatment stage, 2 patients (1VL and 1 PKDL) returned with relapse.
The study demonstrated a Leishmania genus specific closed tube LAMP assay for reliable and rapid molecular diagnosis of VL and PKDL with potential for application in assessment of cure.
利什曼病是一系列与公共卫生密切相关的疾病。传统诊断方法耗时且需要专业人员。因此,需要一种强大、快速且经济高效的诊断测试,以便及时诊断并应用于现场。
我们基于杜氏利什曼原虫的kDNA开发了一种带有引物(n = 6)的环介导等温扩增(LAMP)检测方法,用于检测利什曼原虫感染,该方法采用封闭管以防止交叉污染。该检测方法用于检测从内脏利什曼病(VL)、黑热病后皮肤利什曼病(PKDL)和皮肤利什曼病(CL)患者获得的生物样本中的利什曼原虫感染。
该检测方法对杜氏利什曼原虫、热带利什曼原虫和硕大利什曼原虫呈阳性,对杜氏利什曼原虫的敏感性最高(1 fg DNA)。该检测方法对杜氏利什曼原虫检测的高敏感性体现在其能够在30分钟的扩增时间内检测到寄生虫DNA,每个反应的阈值检测限≥25个拷贝。该检测方法在66份VL血样中的64份中检测到寄生虫(敏感性为96.9%;95%置信区间:89.6 - 99.2%),在15份VL骨髓穿刺样本中的15份中检测到寄生虫(敏感性为100%;95%置信区间:79.6 - 100%),在67份PKDL组织活检样本中的65份中检测到寄生虫(敏感性为97%;95%置信区间:89.7 - 99.2%)。在少数CL病例中对该检测方法进行了评估,发现在10份组织活检样本中的8份呈阳性(敏感性为80%;95%置信区间:49 - 94.3%)。在所有对照血样(n = 76)和组织活检样本(n = 24)中该检测方法均为阴性(特异性为100%;95%置信区间:96.3 - 100%)。此外,还评估了该检测方法在评估治疗后的VL和PKDL患者治愈情况方面的效用。该检测方法在20份VL血样中的2份以及21份PKDL组织样本中的2份中检测到寄生虫DNA。在治疗后阶段寄生虫DNA呈阳性的4例病例中,有2例患者(1例VL和1例PKDL)复发。
该研究证明了一种针对利什曼原虫属的封闭管LAMP检测方法,可用于VL和PKDL的可靠、快速分子诊断,并具有应用于评估治愈情况的潜力。